Yueyang Xingchang Petro-Chemical Co Ltd

Yueyang Xingchang Petro-Chemical Co Ltd has a market price of 16.16 CNY per share and a market capitalization of 5,971,192,816.96 CNY, with a price-to-book ratio of 2.88 and a price-to-tangible-book ratio of 2.88. The company's liquidity is assessed as medium, with a current ratio of 1.18 and a negative net cash position after subtracting total debt. The debt-to-equity ratio is 0.38, indicating a relatively low level of leverage. The company's profitability is weak, with a return on equity of -2.51% and a return on assets of -1.52%. The operating income is negative at -32,864,060 CNY, and the net income is also negative at -52,070,390 CNY. The gross profit is 252,838,720 CNY, but this is insufficient to cover operating expenses. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements. There is no detailed geographic breakdown provided, but the company is based in China and operates within the domestic market. The company's revenue for the latest period is 3,709,975,080 CNY, and the analyst estimate for revenue is 1,588,070,470 CNY. The company's growth trajectory is uncertain, with negative operating and net income figures. The capital expenditure for the period is -315,031,390 CNY, indicating a significant investment in infrastructure or equipment. The free cash flow is negative at -302,004,010 CNY, and the operating cash flow is also negative at -142,099,720 CNY. The company faces liquidity and dilution risks, with a medium liquidity risk and a low dilution risk. The key flag indicating a negative net cash position after subtracting total debt suggests potential liquidity constraints. The company has not issued new shares recently, and there is no indication of dilution pressure in the near term. Recent financial filings and transcripts indicate that the company is experiencing operational challenges, with negative operating and net income figures. The company's financial performance is below industry medians, and there are no recent positive developments reported in the available data.